We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...
EST Cathie Wood’s ARK Investment buys 250K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...
Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...
16h
Zacks.com on MSN10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseGenomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
February 05, 2025, 03:25 AM ET, BY Thomas H. Kee Jr, Editor, Stock Traders Daily | Editor: Derek Curry ( Follow on LinkedIn ) ...
Construction substantially complete and first copper concentrate on track for March (All amounts expressed in U.S. dollars ...
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).
Cathie Wood's ARK ETFs have once again made significant moves in the stock market, as evidenced by the daily trade report for Thursday, February 6th, 2025. The investment management firm, known for ...
4d
24/7 Wall St. on MSNCathie Wood's Top Biotech Plays for FebruaryDon’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...
Life sciences stocks fell Thursday after Science reported that newly imposed restrictions on the NIH by the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results